4//SEC Filing
Jin David 4
Accession 0001104659-24-042504
CIK 0001429260other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:06 PM ET
Size
5.3 KB
Accession
0001104659-24-042504
Insider Transaction Report
Form 4
Jin David
Chief Financial Officer
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2024-04-01$1.70/sh+2,352$3,998→ 238,268 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Total holdings include 230,000 shares underlying deferred restricted stock units.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001930732
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:06 PM ET
- Size
- 5.3 KB